The return of the megamerger
Monday, December 2, 2019 - 01:20
in Mathematics & Economics
Drug companies went on a buying spree in 2019 as they sought to dominate the cancer market and offset competition from generics
Drug companies went on a buying spree in 2019 as they sought to dominate the cancer market and offset competition from generics